@article{1b4e7b37f07948c784f0e4b7d5de567c,
title = "Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries",
abstract = "Children in the Asia Pacific region are still suffering from certain vaccine-preventable diseases. The current study surveyed the national immunization programs and vaccine uptake of traditional and newly developed vaccines in 12 countries in this area. The results showed children in most countries were well protected from conventional vaccine-preventable diseases, while immunization programs for certain diseases such as poliovirus or measles should be strengthened in certain countries. Protection against pneumococcus, rotavirus, and human papillomavirus infections were obviously inadequate in most of the countries in the region. Promoting coverage of newly developed vaccines will benefit a great number of children in this area.",
keywords = "Asia Pacific, Immunization, Preventable diseases, Vaccines",
author = "Lu, {Chun Yi} and Mathuram Santosham and An, {Pham Le} and Ang Kim and Lulu Bravo and Hadinegoro, {Sri Rezeki} and Zulkifli Ismail and Somsak Lolekha and Usa Thisyakorn and Lee, {Bee Wah} and John Wecker",
note = "Funding Information: GSK organized and sponsored the 3rd APECI meeting in Taipei but was not involved in data analysis, manuscript preparation and submission of this article. Chun-Yi Lu has participated in several clinical trials of vaccines developed by GSK, Pfizer, MSD, Aventis and Adimmune. He also received speaker fees from these companies. Lulu Bravo received research grants and honorarium from GSK and Pfizer as well as consultancy honorarium from Novartis. Zulkifli Ismail has served on advisory committees of GSK, Pfizer, Sanofi Pasteur and Novartis Vaccines, and has been involved in local vaccine introductions and launches in Malaysia. Bee Wah Lee has served on advisory committees for GSK, MSD, Pfizer and Novartis. She has also been involved in clinical trials sponsored by GSK, MSD, and Baxter. Somsak Lolekha has served on the advisory committees for GSK, Merck, Pfizer and Novartis. He has also received honoraria as a speaker for Sanofi-Pasteur. Dr. Mathuram Santosham has served on the Advisory Board of GSK, Merck, Pfizer and Sanofi Pasteur and has received honoraria from the respective companies for his services. The other authors did not declare any conflict of interests. ",
year = "2012",
month = mar,
day = "16",
doi = "10.1016/j.vaccine.2011.10.070",
language = "English (US)",
volume = "30",
pages = "2250--2255",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "13",
}